Serum concentration of neopterin on admission does not improve the diagnostic performance of highly-sensitive troponin i

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 4, 2012, Pages 747-748

  Montagnana, Martina ^a   Lippi, Giuseppe ^b   Danese, Elisa ^a   Salvagno, Gian Luca ^a   Cervellin, Gianfranco ^b   Guidi, Gian Cesare ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

acute coronary syndrome; highly sensitive troponin; neopterin

Indexed keywords

NEOPTERIN; TROPONIN I;

ACUTE CORONARY SYNDROME; CAROTID ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; DISEASE MARKER; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC;

CASE-CONTROL STUDIES; EMERGENCY MEDICAL SERVICES; HUMANS; MYOCARDIAL INFARCTION; NEOPTERIN; PATIENT ADMISSION; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 84860480669     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.2011.829     Document Type: Letter

References (12)

1. Gieseg SP, Crone EM, Flavall EA, Amit Z. Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis. Br J Pharmacol 2008;153:627-35. (Pubitemid 351271748)
2. Zouridakis E, Avanzas P, Arroyo-Espliguero R, Fredericks S, Kaski JC. Markers of infl ammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 2004;110:1747-53. (Pubitemid 39299216)
3. Weiss G, Willeit J, Kiechl S, Fuchs D, Jarosch E, Oberhollenzer F, et al. Increased concentrations of neopterin in carotid atherosclerosis. Atherosclerosis 1994;106:263-71. (Pubitemid 24188768)
4. Tanaka T, Nakamura Y, Nasuno A, Mezaki T, Higuchi K, Fukunaga H, et al. Plasma concentrations of monocyte chemoattractant protein 1 (MCP-1) and neopterin in the coronary circulation of patients with coronary artery disease. Association with the severity of coronary atherosclerosis. Circ J 2004;68:114-20. (Pubitemid 38197246)
5. Nazer B, Ray KK, Sloan S, Scirica B, Morrow DA, Cannon CP, et al. Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome. Eur Heart J 2011;32:1390-7.
6. Djordjevic VB, Stojanovic I, Cosic V, Zvezdanovic L, Deljanin- Ilic M, Dimic S, et al. Serum neopterin, nitric oxide, inducible nitric oxide synthase and tumor necrosis factor-alpha levels in patients with ischemic heart disease. Clin Chem Lab Med 2008;46:1149-55.
7. Kavsak PA, MacRae AR, Yerna MJ, Jaffe AS. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 2009;55:573-7.
8. Thygesen K, Alpert JS, White HD, on behalf of the Joint ESC/ ACCF/AHA/WHF Task Force for the redefi nition of myocardial infarction. Universal defi nition of myocardial infarction. J Am Coll Cardiol 2007;50:2173-95. (Pubitemid 350123680)
9. Kaski JC, Consuegra-Sanchez L, Fernandez-Berges DJ, Cruz- Fernandez JM, Garcia-Moll X, Marrugat J, et al; SIESTA Investigators. Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome. Atherosclerosis 2008;201:176-83.
10. Fernández-Bergés D, Bertomeu-Gonzalez V, Sánchez PL, Cruz- Fernandez JM, Arroyo R, Barriales Á lvarez V, et al; SIESTA Study Investigators. Clinical scores and patient risk stratifi cation in non-ST elevation acute coronary syndrome. Int J Cardiol 2011;146:219-24.
11. Wood FO, de Lemos JA. Sorting through new biomarkers. Curr Cardiol Rep 2008;10:319-26.
12. Ray KK, Morrow DA, Sabatine MS, Shui A, Rifai N, Cannon CP, et al. Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome. Circulation 2007;115:3071-8. (Pubitemid 46956496)